Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1136 entries
Sorted by: Best Match Show Resources per page
Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy.

Clinical ophthalmology (Auckland, N.Z.)

Fujita K, Shinoda K, Matsumoto CS, Imamura Y, Tanaka E, Mizutani Y, Mizota A, Yuzawa M.
PMID: 23097612
Clin Ophthalmol. 2012;6:1681-7. doi: 10.2147/OPTH.S35338. Epub 2012 Oct 16.

BACKGROUND: The purpose of this study was to determine baseline clinical factors to correlate the outcome of half-dose verteporfin photodynamic therapy (PDT) in eyes with chronic central serous chorioretinopathy (CSC).METHODS: In this prospective, non-comparative, interventional case series, 14 eyes...

Cite
Fujita K, Shinoda K, Matsumoto CS, et al. Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy. Clin Ophthalmol. 2012;6:1681-7doi: 10.2147/OPTH.S35338.
Fujita, K., Shinoda, K., Matsumoto, C. S., Imamura, Y., Tanaka, E., Mizutani, Y., Mizota, A., & Yuzawa, M. (2012). Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy. Clinical ophthalmology (Auckland, N.Z.), 61681-7. https://doi.org/10.2147/OPTH.S35338
Fujita, Kyoko, et al. "Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy." Clinical ophthalmology (Auckland, N.Z.) vol. 6 (2012): 1681-7. doi: https://doi.org/10.2147/OPTH.S35338
Fujita K, Shinoda K, Matsumoto CS, Imamura Y, Tanaka E, Mizutani Y, Mizota A, Yuzawa M. Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy. Clin Ophthalmol. 2012;6:1681-7. doi: 10.2147/OPTH.S35338. Epub 2012 Oct 16. PMID: 23097612; PMCID: PMC3476484.
Copy Download .nbib Format: NLM
Fast Coding of Feature Vectors Using Neighbor-to-Neighbor Search.

IEEE transactions on pattern analysis and machine intelligence

Inoue N, Shinoda K.
PMID: 26415151
IEEE Trans Pattern Anal Mach Intell. 2016 Jun;38(6):1170-84. doi: 10.1109/TPAMI.2015.2481390. Epub 2015 Sep 23.

Searching for matches to high-dimensional vectors using hard/soft vector quantization is the most computationally expensive part of various computer vision algorithms including the bag of visual word (BoW). This paper proposes a fast computation method, Neighbor-to-Neighbor (NTN) search [1]...

Cite
Inoue N, Shinoda K. Fast Coding of Feature Vectors Using Neighbor-to-Neighbor Search. IEEE Trans Pattern Anal Mach Intell. 2015;38(6):1170-84doi: 10.1109/TPAMI.2015.2481390.
Inoue, N., & Shinoda, K. (2016). Fast Coding of Feature Vectors Using Neighbor-to-Neighbor Search. IEEE transactions on pattern analysis and machine intelligence, 38(6), 1170-84. https://doi.org/10.1109/TPAMI.2015.2481390
Inoue, Nakamasa, and Shinoda, Koichi. "Fast Coding of Feature Vectors Using Neighbor-to-Neighbor Search." IEEE transactions on pattern analysis and machine intelligence vol. 38,6 (2016): 1170-84. doi: https://doi.org/10.1109/TPAMI.2015.2481390
Inoue N, Shinoda K. Fast Coding of Feature Vectors Using Neighbor-to-Neighbor Search. IEEE Trans Pattern Anal Mach Intell. 2016 Jun;38(6):1170-84. doi: 10.1109/TPAMI.2015.2481390. Epub 2015 Sep 23. PMID: 26415151.
Copy Download .nbib Format: NLM
Phosphorylation of p38 in Trigeminal Ganglion Neurons Contributes to Tongue Heat Hypersensitivity in Mice.

Journal of oral & facial pain and headache

Maruno M, Shinoda M, Honda K, Ito R, Urata K, Watanabe M, Okada S, Lee J, Gionhaku N, Iwata K.
PMID: 28973050
J Oral Facial Pain Headache. 2017;31(4):372–380. doi: 10.11607/ofph.1849. Epub 2017 Oct 03.

AIMS: To develop a tongue pain model with no mucosal pathologic changes and to examine whether phosphorylation of p38 in trigeminal ganglion (TG) neurons innervating the tongue is associated with tongue heat hypersensitivity in mice.METHODS: Tongue heat sensitivity in...

Cite
Maruno M, Shinoda M, Honda K, et al. Phosphorylation of p38 in Trigeminal Ganglion Neurons Contributes to Tongue Heat Hypersensitivity in Mice. J Oral Facial Pain Headache. 2017;31(4):372–380doi: 10.11607/ofph.1849.
Maruno, M., Shinoda, M., Honda, K., Ito, R., Urata, K., Watanabe, M., Okada, S., Lee, J., Gionhaku, N., & Iwata, K. (2017). Phosphorylation of p38 in Trigeminal Ganglion Neurons Contributes to Tongue Heat Hypersensitivity in Mice. Journal of oral & facial pain and headache, 31(4), 372–380. https://doi.org/10.11607/ofph.1849
Maruno, Mitsuru, et al. "Phosphorylation of p38 in Trigeminal Ganglion Neurons Contributes to Tongue Heat Hypersensitivity in Mice." Journal of oral & facial pain and headache vol. 31,4 (2017): 372–380. doi: https://doi.org/10.11607/ofph.1849
Maruno M, Shinoda M, Honda K, Ito R, Urata K, Watanabe M, Okada S, Lee J, Gionhaku N, Iwata K. Phosphorylation of p38 in Trigeminal Ganglion Neurons Contributes to Tongue Heat Hypersensitivity in Mice. J Oral Facial Pain Headache. 2017;31(4):372–380. doi: 10.11607/ofph.1849. Epub 2017 Oct 03. PMID: 28973050.
Copy Download .nbib Format: NLM
Temporal lobe epilepsy associated with GAD autoimmunity.

Acta diabetologica

Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.
PMID: 27638303
Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 08.

No abstract available.

Cite
Obata A, Kutoku Y, Sunada Y, et al. Temporal lobe epilepsy associated with GAD autoimmunity. Acta Diabetol. 2016;54(3):321-323doi: 10.1007/s00592-016-0910-9.
Obata, A., Kutoku, Y., Sunada, Y., Okauchi, S., Kimura, T., Hirukawa, H., Tanabe, A., Kinoshita, T., Kohara, K., Tatsumi, F., Shimoda, M., Kamei, S., Nakanishi, S., Mune, T., Kaku, K., & Kaneto, H. (2017). Temporal lobe epilepsy associated with GAD autoimmunity. Acta diabetologica, 54(3), 321-323. https://doi.org/10.1007/s00592-016-0910-9
Obata, Atsushi, et al. "Temporal lobe epilepsy associated with GAD autoimmunity." Acta diabetologica vol. 54,3 (2017): 321-323. doi: https://doi.org/10.1007/s00592-016-0910-9
Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H. Temporal lobe epilepsy associated with GAD autoimmunity. Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 08. PMID: 27638303; PMCID: PMC5329084.
Copy Download .nbib Format: NLM
Lung sound analysis helps localize airway inflammation in patients with bronchial asthma.

Journal of asthma and allergy

Shimoda T, Obase Y, Nagasaka Y, Nakano H, Ishimatsu A, Kishikawa R, Iwanaga T.
PMID: 28392708
J Asthma Allergy. 2017 Mar 27;10:99-108. doi: 10.2147/JAA.S125938. eCollection 2017.

No abstract available.

Cite
Shimoda T, Obase Y, Nagasaka Y, et al. Lung sound analysis helps localize airway inflammation in patients with bronchial asthma. J Asthma Allergy. 2017;10:99-108doi: 10.2147/JAA.S125938.
Shimoda, T., Obase, Y., Nagasaka, Y., Nakano, H., Ishimatsu, A., Kishikawa, R., & Iwanaga, T. (2017). Lung sound analysis helps localize airway inflammation in patients with bronchial asthma. Journal of asthma and allergy, 1099-108. https://doi.org/10.2147/JAA.S125938
Shimoda, Terufumi, et al. "Lung sound analysis helps localize airway inflammation in patients with bronchial asthma." Journal of asthma and allergy vol. 10 (2017): 99-108. doi: https://doi.org/10.2147/JAA.S125938
Shimoda T, Obase Y, Nagasaka Y, Nakano H, Ishimatsu A, Kishikawa R, Iwanaga T. Lung sound analysis helps localize airway inflammation in patients with bronchial asthma. J Asthma Allergy. 2017 Mar 27;10:99-108. doi: 10.2147/JAA.S125938. eCollection 2017. PMID: 28392708; PMCID: PMC5376185.
Copy Download .nbib Format: NLM
The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years.

American journal of clinical and experimental urology

Kosaka T, Mizuno R, Shinojima T, Miyajima A, Kikuchi E, Tanaka N, Shinoda K, Morita S, Mikami S, Oya M.
PMID: 25606579
Am J Clin Exp Urol. 2014 Dec 25;2(4):332-6. eCollection 2014.

To investigate the appropriate cut-off level of PSA or other clinical parameters at aged ≤ 50 years. The rate of detection of PCa in young men will continue to rise associated with the advancement of the current and evolving...

Cite
Kosaka T, Mizuno R, Shinojima T, et al. The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years. Am J Clin Exp Urol. 2014;2(4):332-6
Kosaka, T., Mizuno, R., Shinojima, T., Miyajima, A., Kikuchi, E., Tanaka, N., Shinoda, K., Morita, S., Mikami, S., & Oya, M. (2014). The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years. American journal of clinical and experimental urology, 2(4), 332-6.
Kosaka, Takeo, et al. "The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years." American journal of clinical and experimental urology vol. 2,4 (2014): 332-6.
Kosaka T, Mizuno R, Shinojima T, Miyajima A, Kikuchi E, Tanaka N, Shinoda K, Morita S, Mikami S, Oya M. The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years. Am J Clin Exp Urol. 2014 Dec 25;2(4):332-6. eCollection 2014. PMID: 25606579; PMCID: PMC4297329.
Copy Download .nbib Format: NLM
Evaluation and Management of Concomitant Hypertrophic Obstructive Cardiomyopathy and Valvular Aortic Stenosis.

Current treatment options in cardiovascular medicine

Shenouda J, Silber D, Subramaniam M, Alkhatib B, Schwartz RK, Goncalves JA, Naidu SS.
PMID: 26874705
Curr Treat Options Cardiovasc Med. 2016 Mar;18(3):17. doi: 10.1007/s11936-016-0440-3.

OPINION STATEMENT: The dilemma of the patient with both AS and LVOTO is now commonly encountered in clinical practice; indeed, physicians must be aware of the complex interaction and coexistent nature of both diseases, especially as both HOCM and...

Cite
Shenouda J, Silber D, Subramaniam M, et al. Evaluation and Management of Concomitant Hypertrophic Obstructive Cardiomyopathy and Valvular Aortic Stenosis. Curr Treat Options Cardiovasc Med. 2016;18(3):17doi: 10.1007/s11936-016-0440-3.
Shenouda, J., Silber, D., Subramaniam, M., Alkhatib, B., Schwartz, R. K., Goncalves, J. A., & Naidu, S. S. (2016). Evaluation and Management of Concomitant Hypertrophic Obstructive Cardiomyopathy and Valvular Aortic Stenosis. Current treatment options in cardiovascular medicine, 18(3), 17. https://doi.org/10.1007/s11936-016-0440-3
Shenouda, John, et al. "Evaluation and Management of Concomitant Hypertrophic Obstructive Cardiomyopathy and Valvular Aortic Stenosis." Current treatment options in cardiovascular medicine vol. 18,3 (2016): 17. doi: https://doi.org/10.1007/s11936-016-0440-3
Shenouda J, Silber D, Subramaniam M, Alkhatib B, Schwartz RK, Goncalves JA, Naidu SS. Evaluation and Management of Concomitant Hypertrophic Obstructive Cardiomyopathy and Valvular Aortic Stenosis. Curr Treat Options Cardiovasc Med. 2016 Mar;18(3):17. doi: 10.1007/s11936-016-0440-3. PMID: 26874705.
Copy Download .nbib Format: NLM
Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis.

World journal of gastrointestinal endoscopy

Hayashi S, Nishida T, Shimakoshi H, Shimoda A, Amano T, Sugimoto A, Takahashi K, Mukai K, Matsubara T, Yamamoto M, Nakajima S, Fukui K, Inada M.
PMID: 28042392
World J Gastrointest Endosc. 2016 Dec 16;8(20):777-784. doi: 10.4253/wjge.v8.i20.777.

AIM: To estimate the efficacy of 2 h post-endoscopic retrograde cholangiopancreatography (ERCP) serum amylase levels and other factors for predicting post-ERCP pancreatitis.METHODS: This was a retrospective, single-center cohort study of consecutive patients who underwent ERCP from January 2010 to...

Cite
Hayashi S, Nishida T, Shimakoshi H, et al. Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Endosc. 2016;8(20):777-784doi: 10.4253/wjge.v8.i20.777.
Hayashi, S., Nishida, T., Shimakoshi, H., Shimoda, A., Amano, T., Sugimoto, A., Takahashi, K., Mukai, K., Matsubara, T., Yamamoto, M., Nakajima, S., Fukui, K., & Inada, M. (2016). Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis. World journal of gastrointestinal endoscopy, 8(20), 777-784. https://doi.org/10.4253/wjge.v8.i20.777
Hayashi, Shiro, et al. "Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis." World journal of gastrointestinal endoscopy vol. 8,20 (2016): 777-784. doi: https://doi.org/10.4253/wjge.v8.i20.777
Hayashi S, Nishida T, Shimakoshi H, Shimoda A, Amano T, Sugimoto A, Takahashi K, Mukai K, Matsubara T, Yamamoto M, Nakajima S, Fukui K, Inada M. Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Endosc. 2016 Dec 16;8(20):777-784. doi: 10.4253/wjge.v8.i20.777. PMID: 28042392; PMCID: PMC5159676.
Copy Download .nbib Format: NLM
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis.

Neuro-oncology practice

Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI.
PMID: 27833757
Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07.

BACKGROUND: Brain radiation necrosis (BRN) can be a complication of radiotherapy for primary and secondary brain tumors, as well as head and neck tumors. Since vascular endothelial growth factor (VEGF) is also a vascular permeability factor in the brain,...

Cite
Furuse M, Nonoguchi N, Kuroiwa T, et al. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016;3(4):272-280doi: 10.1093/nop/npv064.
Furuse, M., Nonoguchi, N., Kuroiwa, T., Miyamoto, S., Arakawa, Y., Shinoda, J., Miwa, K., Iuchi, T., Tsuboi, K., Houkin, K., Terasaka, S., Tabei, Y., Nakamura, H., Nagane, M., Sugiyama, K., Terasaki, M., Abe, T., Narita, Y., Saito, N., Mukasa, A., Ogasawara, K., Beppu, T., Kumabe, T., Nariai, T., Tsuyuguchi, N., Nakatani, E., Kurisu, S., Nakagawa, Y., & Miyatake, S. I. (2016). A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neuro-oncology practice, 3(4), 272-280. https://doi.org/10.1093/nop/npv064
Furuse, Motomasa, et al. "A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis." Neuro-oncology practice vol. 3,4 (2016): 272-280. doi: https://doi.org/10.1093/nop/npv064
Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07. PMID: 27833757; PMCID: PMC5099992.
Copy Download .nbib Format: NLM
Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance.

Adipocyte

Niijima K, Shimoda Y, Saito T, Yamada E, Niijima Y, Okada S, Yamada M.
PMID: 27994951
Adipocyte. 2016 Sep 27;5(4):375-377. doi: 10.1080/21623945.2016.1240138. eCollection 2016.

To assess whether there is any clinical significance for determining the normal range of subcutaneous abdominal fat area, we compared fat area with insulin sensitivity. Visceral and subcutaneous abdominal fat area the L4-L5 thoracic level was determined by computed...

Cite
Niijima K, Shimoda Y, Saito T, et al. Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance. Adipocyte. 2016;5(4):375-377doi: 10.1080/21623945.2016.1240138.
Niijima, K., Shimoda, Y., Saito, T., Yamada, E., Niijima, Y., Okada, S., & Yamada, M. (2016). Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance. Adipocyte, 5(4), 375-377. https://doi.org/10.1080/21623945.2016.1240138
Niijima, Katsura, et al. "Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance." Adipocyte vol. 5,4 (2016): 375-377. doi: https://doi.org/10.1080/21623945.2016.1240138
Niijima K, Shimoda Y, Saito T, Yamada E, Niijima Y, Okada S, Yamada M. Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance. Adipocyte. 2016 Sep 27;5(4):375-377. doi: 10.1080/21623945.2016.1240138. eCollection 2016. PMID: 27994951; PMCID: PMC5160386.
Copy Download .nbib Format: NLM
Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection.

Hepatology research : the official journal of the Japan Society of Hepatology

Yamada Y, Hoshino K, Mori T, Kawaida M, Abe K, Ishihama H, Shimizu T, Takahashi N, Matsubara K, Hibi T, Abe Y, Yagi H, Shimojima N, Shinoda M, Kitago M, Obara H, Fuchimoto Y, Kameyama K, Kitagawa Y, Kuroda T.
PMID: 28626871
Hepatol Res. 2018 Feb;48(3):E360-E366. doi: 10.1111/hepr.12924. Epub 2017 Aug 16.

Growing evidence suggests a relationship between antibody-mediated rejection (AMR) and early graft failure due to a previously unknown etiology in liver transplantation (LTx). We herein report a 3-year-old boy who developed rapid graft failure due to de novo donor-specific...

Cite
Yamada Y, Hoshino K, Mori T, et al. Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection. Hepatol Res. 2017;48(3):E360-E366doi: 10.1111/hepr.12924.
Yamada, Y., Hoshino, K., Mori, T., Kawaida, M., Abe, K., Ishihama, H., Shimizu, T., Takahashi, N., Matsubara, K., Hibi, T., Abe, Y., Yagi, H., Shimojima, N., Shinoda, M., Kitago, M., Obara, H., Fuchimoto, Y., Kameyama, K., Kitagawa, Y., & Kuroda, T. (2018). Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection. Hepatology research : the official journal of the Japan Society of Hepatology, 48(3), E360-E366. https://doi.org/10.1111/hepr.12924
Yamada, Yohei, et al. "Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection." Hepatology research : the official journal of the Japan Society of Hepatology vol. 48,3 (2018): E360-E366. doi: https://doi.org/10.1111/hepr.12924
Yamada Y, Hoshino K, Mori T, Kawaida M, Abe K, Ishihama H, Shimizu T, Takahashi N, Matsubara K, Hibi T, Abe Y, Yagi H, Shimojima N, Shinoda M, Kitago M, Obara H, Fuchimoto Y, Kameyama K, Kitagawa Y, Kuroda T. Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection. Hepatol Res. 2018 Feb;48(3):E360-E366. doi: 10.1111/hepr.12924. Epub 2017 Aug 16. PMID: 28626871.
Copy Download .nbib Format: NLM
Inflammatory diarrhea due to enteroaggregative Escherichia coli: evidence from clinical and mice model studies.

Gut pathogens

Saha DR, Guin S, Krishnan R, Nag D, Koley H, Shinoda S, Ramamurthy T.
PMID: 24294997
Gut Pathog. 2013 Dec 03;5(1):36. doi: 10.1186/1757-4749-5-36.

BACKGROUND: This study was conducted to determine the role of enteroaggregative Escherichia coli (EAEC) in inflammatory diarrhea among hospitalized patients in Kolkata. The inflammatory pathogenesis of EAEC was established in mice model and histopathological studies. Presence of fecal leucocytes...

Cite
Saha DR, Guin S, Krishnan R, et al. Inflammatory diarrhea due to enteroaggregative Escherichia coli: evidence from clinical and mice model studies. Gut Pathog. 2013;5(1):36doi: 10.1186/1757-4749-5-36.
Saha, D. R., Guin, S., Krishnan, R., Nag, D., Koley, H., Shinoda, S., & Ramamurthy, T. (2013). Inflammatory diarrhea due to enteroaggregative Escherichia coli: evidence from clinical and mice model studies. Gut pathogens, 5(1), 36. https://doi.org/10.1186/1757-4749-5-36
Saha, Dhira Rani, et al. "Inflammatory diarrhea due to enteroaggregative Escherichia coli: evidence from clinical and mice model studies." Gut pathogens vol. 5,1 (2013): 36. doi: https://doi.org/10.1186/1757-4749-5-36
Saha DR, Guin S, Krishnan R, Nag D, Koley H, Shinoda S, Ramamurthy T. Inflammatory diarrhea due to enteroaggregative Escherichia coli: evidence from clinical and mice model studies. Gut Pathog. 2013 Dec 03;5(1):36. doi: 10.1186/1757-4749-5-36. PMID: 24294997; PMCID: PMC4176733.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1136 entries